Immunocore Holdings plc Net Foreign Exchange Gain
Immunocore Holdings plc (IMCR) reported Net Foreign Exchange Gain of GBP 15.18 million for the 3-month period ending 2022-09-30, per its 6-K/A filed 2022-11-18.
Discontinued › Income Statement › Other Income
ifrs-full:NetForeignExchangeGain · last filed 2022-11-18
- Immunocore Holdings plc net foreign exchange gain for the quarter ending 2022-09-30 was 15.18M GBP, a 354.88% increase year-over-year.
- Immunocore Holdings plc net foreign exchange gain for the quarter ending 2021-09-30 was 3.34M GBP.
| Period end | Net Foreign Exchange Gain 3 month | Net Foreign Exchange Gain 9 month |
|---|---|---|
| 2022-09-30 | 15.18M GBP 6-K/A · filed 2022-11-18 | 24.34M GBP 6-K/A · filed 2022-11-18 |
| 2021-09-30 | 3.34M GBP 6-K/A · filed 2022-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |